HRCM
TWST icon

Hawk Ridge Capital Management’s Twist Bioscience TWST Stock Holding History

Hawk Ridge Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-234,300
Closed -$8.62M – 61
2025
Q2 		$8.62M Buy
234,300
+75,594
+48% +$2.61M 0.36% 46
2025
Q1 		$6.23M Sell
158,706
-128,794
-45% -$5.8M 0.29% 38
2024
Q4 		$13.4M Buy
+287,500
New +$13M 0.64% 33

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Hawk Ridge Capital Management's TWST Position: Q3 2025 in Review

Hawk Ridge Capital Management sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 234,300 shares — an estimated $8.62M sold.

Hawk Ridge Capital Management first reported a position in TWST in Q4 2024 and held it in 3 quarters. The position peaked at $13.4M in Q4 2024. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

  • Hawk Ridge Capital Management reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
  • Hawk Ridge Capital Management sold 234,300 Twist Bioscience shares in Q3 2025, an estimated $8.62M.
  • Hawk Ridge Capital Management first reported a position in Twist Bioscience in Q4 2024 and held it in 3 quarters.
  • Hawk Ridge Capital Management's Twist Bioscience position peaked at $13.4M in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Hawk Ridge Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.